Glenmark Pharmaceuticals Limited: Detailed financials

Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.

Company financials

Particulars	Sep-24	Dec-24	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26
	3,434	3,388	3,256	3,264	6,047	3,901	3,771	4,018
	39	31	12	26	201	44	189	66
	3,001	2,962	2,887	2,872	3,895	3,227	3,199	3,441
	774	746	795	732	723	775	731	601
	443	418	345	581	620	749	446	661
	−147	−80	−51	−298	−78	−229	−5	−16
	787	788	737	763	1,086	841	887	935
	48	52	67	58	66	41	43	54
	120	123	125	130	141	154	148	173
	975	915	870	906	1,337	894	948	1,033
	641	631	200	284	1,175	730	578	871
	521	509	75	154	1,034	575	430	697
	—	—	−373	−323	−1,385	−184	−373	—
	473	456	8	96	967	534	388	643
	118	108	4	49	357	131	86	161
	354	348	4	47	610	403	301	483
Financial ratios
	18.68%	18.64%	6.14%	8.69%	19.43%	18.71%	15.34%	21.66%
	10.32%	10.27%	0.13%	1.44%	10.09%	10.34%	7.99%	12.02%
	12.55	12.33	0.16	1.66	21.63	14.29	10.68	17.11

Revenue

₹ crore

Select any table row to compare its reported history.

Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.